DERMATOLOGY THER 润色咨询

Dermatology and Therapy

出版年份:1976 年文章数:615 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=128013418, cover=https://img.medsci.cn/images/journal/cover/2021/Fne_202109271314511360.jpg, fullname=Dermatology and Therapy, abbr=DERMATOLOGY THER, pyear=1976, frequence=Bimonthly, articleNumbers=615, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2193-8210, greenSci=https://www.greensci.net/search?kw=2193-8210, scijournal=https://www.scijournal.org/impact-factor-of-DERMATOLOGY-THER.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.861, medsciHotlight=1.958, medsciHotlight5year=0.805, citescore=4.8, hIndex=27, impactFactor=3.4, orgnization=Springer Verlag, orgnizationUrl=, country=Germany, countryCn=德国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded (SciSearch)|Journal Citation Reports/Science Edition|PubMed Central|SCOPUS|EMBASE|Google Scholar|Current Contents/Clinical Medicine|DOAJ|EBSCO|MedSci, bigclassCas=医学 2区, smallclassCas=医学 3 区, website=http://www.ncbi.nlm.nih.gov/pmc/journals/1900/, websiteHits=1360, guideForAuthor=https://www.springer.com/cda/content/document/cda_downloaddocument/Adis+Rapid%2B+I4A+V4.0.pdf?SGWID=0-0-45-1101137-p174307257, guideForAuthorHits=386, submitWebsite=https://www.editorialmanager.com/derm/, submitWebsiteHits=935, content=<!--ewebeditor:page title=""--> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;"><em>Dermatology and Therapy</em> is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published in <em>Dermatology and Therapy</em> may be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">Moving forward from traditional publishing, <em>Dermatology and Therapy</em> offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself. For questions relating to enhanced features please contact adisdigitalfeatures@springer.com.</p> <!--/ewebeditor:page--> <p> </p> <!--ewebeditor:page title=""--> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;"><em>Dermatology and Therapy</em> is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">Upon acceptance of your article for publication, you will be required to pay the article processing charge of €340/ $380 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;"><strong>Peer Review Process</strong></p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive double-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.</p> <p style="margin: 0px 0px 0.5em; padding: 0px; border: 0px; line-height: 18px; font-family: myriad, arial, sans-serif; color: #666666;">At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.</p> <!--/ewebeditor:page--> <p> </p>, totalCites=2094, brief=DERMATOLOGY THER杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=DERMATOLOGY THER杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=128013418'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=65682, tagName=皮肤病学, createdHits=2), ImpactFactorTagDto(id=4418, tagName=银屑病, createdHits=1), ImpactFactorTagDto(id=14834, tagName=白癜风, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=1.548), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.477), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=5.01), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.951), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.861)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Dermatology , rank=5/128)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2193-8210[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Dermatology and Therapy[ta], article_number=201, article_number_cn=18, earlyWarning=不在预警名单中, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
DERMATOLOGY THER/Dermatology and Therapy
ISSN
2193-8210
影响指数话题
预警等级
不在预警名单中
MedSci期刊指数
2.861 (MedSci实时期刊指数) | 0.805 (5年期刊指数)
CiteScore值
4.8
h-index
27
h5-median
暂无数据
出版社/管理机构
杂志由 Springer Verlag 出版或管理
出版国家/地区
Germany 德国
出版周期
Bimonthly
出版年份
1976
是否OA
被收录情况
Science Citation Index Expanded (SciSearch)|Journal Citation Reports/Science Edition|PubMed Central|SCOPUS|EMBASE|Google Scholar|Current Contents/Clinical Medicine|DOAJ|EBSCO|MedSci
JCR分区
暂无数据
中科院分区
大类:医学 2区
小类:医学 3 区